Finance

Beta
Lists
3320:HKG
China Resources Pharmaceutical Group Ltd
HK$4.75
+0.42%
(+0.020) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3320...
Open
HK$4.73
High
HK$4.76
Low
HK$4.67
Mkt. cap
29.84B
Avg. vol.
12.10M
Volume
7.78M
Dividend
4.59%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 3, 2026
P/E ratio
6.38
52-wk high
HK$6.53
52-wk low
HK$4.34
EPS
HK$0.74
Shares outstanding
6.28B
No. of employees
86K
Open
HK$4.73
High
HK$4.76
Low
HK$4.67
Mkt. cap
29.84B
Avg. vol.
12.10M
Volume
7.78M
Dividend
4.59%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 3, 2026
P/E ratio
6.38
52-wk high
HK$6.53
52-wk low
HK$4.34
EPS
HK$0.74
Shares outstanding
6.28B
No. of employees
86K
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to 3320 in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for 3320 in the last 3 months.
Highest
Current HK$4.75
HK$7.46 (+57.15%)
Average
HK$6.68 (+40.72%)
Lowest
HK$5.86 (+23.30%)
News stories
From sources across the web
About China Resources Pharmaceutical Group Ltd
CEOBai Xiaosong
Employees85.6K
Founded2007
Headquarters-
SectorPharmaceutical industry
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
65.93B
65.93B
68.85B
68.85B
Cost of goods sold
55.18B
55.18B
57.35B
57.35B
Cost of revenue
55.18B
55.18B
57.35B
57.35B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.60B
6.60B
7.99B
7.99B
Operating expense
7.12B
7.12B
8.81B
8.81B
Total operating expenses
62.30B
62.30B
66.17B
66.17B
Operating income
3.64B
3.64B
2.69B
2.69B
Other non operating income
61.25M
61.25M
517.21M
517.21M
EBT including unusual items
3.21B
3.21B
2.69B
2.69B
EBT excluding unusual items
3.39B
3.39B
2.88B
2.88B
Income tax expense
681.16M
681.16M
390.24M
390.24M
Effective tax rate
21.23%
21.23%
14.51%
14.51%
Other operating expenses
519.19M
519.19M
818.33M
818.33M
Net income
1.04B
1.04B
984.09M
984.09M
Net profit margin
1.58%
1.58%
1.43%
1.43%
Earnings per share
-
-
-
-
Interest and investment income
135.64M
135.64M
106.35M
106.35M
Interest expense
-502.06M
-502.06M
-504.31M
-504.31M
Net interest expenses
-366.42M
-366.42M
-397.97M
-397.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.38B
4.38B
3.57B
3.57B
Gain or loss from assets sale
-1.98M
-1.98M
-19.57M
-19.57M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more